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Introduction
Chronic cough (CC), a cough that lasts more 
than eight weeks, is the number one complaint 
of adults seeking non-emergent medical care1. 
An estimated 20% of patients with CC do not 
respond to medical treatment, and are said to 
have refractory chronic cough (RCC)1-3. Several 
studies provide evidence that RCC is caused by 
hypersensitivity of sensory protein receptors in 
the airway epithelium known to regulate 
cough1-12. The primary sensory receptors are 
the transient receptor potential vanilloid
(TRPV)4-8. These receptors can be found in the 
epithelial layer of the bronchus, larynx and 
nose9. These receptors are very plastic; in other 
words they are easily influenced by 
endogenous and exogenous factors, such as 
inflammation and chemical or mechanical 
stimulation. Behavioral cough therapy (BCT), 
which is provided by speech-language 
pathologists, has been shown to result in 
reduced cough sensitivity10-13. However, the 
underlying mechanism that results in reduced 
cough sensitivity is unknown.
VOICES (Voice Outcomes and Inquiry of 
Cough and Essentials in Swallowing) Lab
Hypothesis
The reduction in cough sensitivity is due to down-
modulation of TRPV receptors through a 
neuroplastic mechanism.
1. Obtain 
biopsy of nose 
and larynx 
epithelial 
tissue pre-BCT
2. Analyze 
TRPV protein 
expression 
and subtype 
via Western
3. Analyze 
expression of 
TRPV mRNA 
via qPCR
4. Patients 
complete  
3-4 weeks 
of BCT
5. Repeat 
steps 1-4 
post-BCT, 
establish 
methods 
Rationale
• Establish feasible methods
• Explore neuroplastic mechanism of 
reducing cough hypersensitivity
Methods
References
Implications
Examining the expression of TRPV 
before and after BCT will potentially 
explain the mechanism of the effect of 
BCT, which may increase its application 
in the clinic as well as open doors to 
other potential treatments for RCC.
BCT
Cough Suppression Strategies
• Cough control breathing
• non-medicated lozenge 
• sip water 
• hard swallow 
• breath hold
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